Abstract

Stroke affects millions of people worldwide each year. There are some types of stroke like ischemic stroke, when stroke patients need secondary prevention of new events. One of the options of a secondary prevention is through the use of oral anticoagulants such as dabigatran, rivaroxaban (direct oral anticoagulants - DOACS) and warfarin; however, the home use of such drugs is a matter of concern due to the risks of Adverse Drug Reaction (ADR) related to poor adherence to drug treatment, in addition to the difficulty of access to the drug by the population.

Keywords

neurology, stroke, clinical pharmacy, oral anticoagulants, adherence, adr, multidisciplinary team, SUS